397 related articles for article (PubMed ID: 17425654)
1. Skewed T cell receptor repertoire of Vdelta1(+) gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction.
Fujishima N; Hirokawa M; Fujishima M; Yamashita J; Saitoh H; Ichikawa Y; Horiuchi T; Kawabata Y; Sawada KI
Clin Exp Immunol; 2007 Jul; 149(1):70-9. PubMed ID: 17425654
[TBL] [Abstract][Full Text] [Related]
2. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft.
Hirokawa M; Horiuchi T; Kawabata Y; Kitabayashi A; Miura AB
Bone Marrow Transplant; 2000 Jul; 26(2):177-85. PubMed ID: 10918428
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90 expression in Epstein-Barr virus-infected B cells promotes gammadelta T-cell proliferation in vitro.
Kotsiopriftis M; Tanner JE; Alfieri C
J Virol; 2005 Jun; 79(11):7255-61. PubMed ID: 15890964
[TBL] [Abstract][Full Text] [Related]
5. Identification of the T cell clones expanding within both CD8(+)CD28(+) and CD8(+)CD28(-) T cell subsets in recipients of allogeneic hematopoietic cell grafts and its implication in post-transplant skewing of T cell receptor repertoire.
Horiuchi T; Hirokawa M; Kawabata Y; Kitabayashi A; Matsutani T; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB
Bone Marrow Transplant; 2001 Apr; 27(7):731-9. PubMed ID: 11360114
[TBL] [Abstract][Full Text] [Related]
6. Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells.
Orsini DL; van Gils M; Kooy YM; Struyk L; Klein G; van den Elsen P; Koning F
Eur J Immunol; 1994 Dec; 24(12):3199-204. PubMed ID: 7528674
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
[TBL] [Abstract][Full Text] [Related]
8. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
Ruf S; Behnke-Hall K; Gruhn B; Bauer J; Horn M; Beck J; Reiter A; Wagner HJ
J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
[TBL] [Abstract][Full Text] [Related]
9. Extensive clonal expansion of T lymphocytes causes contracted diversity of complementarity-determining region 3 and skewed T cell receptor repertoires after allogeneic hematopoietic cell transplantation.
Hirokawa M; Matsutani T; Horiuchi T; Kawabata Y; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB
Bone Marrow Transplant; 2001 Mar; 27(6):607-14. PubMed ID: 11319590
[TBL] [Abstract][Full Text] [Related]
10. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D
Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
[TBL] [Abstract][Full Text] [Related]
11. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
12. CDR3-independent expansion of Vδ1 T lymphocytes in acquired chronic pure red cell aplasia.
Michishita Y; Hirokawa M; Fujishima N; Abe Y; Fujishima M; Guo YM; Ubukawa K; Liu J; Yoshioka T; Kameoka Y; Saitoh H; Tagawa H; Takahashi N; Sawada K
Immunol Lett; 2013 Feb; 150(1-2):23-9. PubMed ID: 23274961
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
14. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
[TBL] [Abstract][Full Text] [Related]
15. CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.
Sukdolak C; Tischer S; Dieks D; Figueiredo C; Goudeva L; Heuft HG; Verboom M; Immenschuh S; Heim A; Borchers S; Mischak-Weissinger E; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1480-92. PubMed ID: 23891747
[TBL] [Abstract][Full Text] [Related]
16. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
Hyjek EM; Bartkowiak J; Drozdz R; Wasik TJ; Jasinski M; Kaneko Y; Lischner HW; Kozbor D
J Immunol; 1997 Jan; 158(1):464-74. PubMed ID: 8977224
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
18. Characterization of γδ T cell subsets in organ transplantation.
Puig-Pey I; Bohne F; Benítez C; López M; Martínez-Llordella M; Oppenheimer F; Lozano JJ; González-Abraldes J; Tisone G; Rimola A; Sánchez-Fueyo A
Transpl Int; 2010 Oct; 23(10):1045-55. PubMed ID: 20477999
[TBL] [Abstract][Full Text] [Related]
19. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
[TBL] [Abstract][Full Text] [Related]
20. Selective activation of TCR-gammadelta+ cells in endemic Burkitt's lymphoma.
Futagbi G; Welbeck JE; Tetteh JK; Hviid L; Akanmori BD
Malar J; 2007 May; 6():69. PubMed ID: 17521425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
